Captor Therapeutics SA
F:60Q
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Captor Therapeutics SA
F:60Q
|
PL |
|
Stella-Jones Inc
F:97S
|
CA |
|
Adevinta ASA
OSE:ADE
|
NO |
|
Laboratorio Reig Jofre SA
F:FEQ1
|
ES |
|
A
|
AECC Aviation Power Co Ltd
SSE:600893
|
CN |
|
C
|
Cyberark Software Ltd
SWB:CYB
|
IL |
Wall St Price Targets
60Q Price Targets Summary
Captor Therapeutics SA
According to Wall Street analysts, the average 1-year price target for 60Q is 14.86 EUR with a low forecast of 14.72 EUR and a high forecast of 15.3 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 60Q's stock price target?
Price Target
14.86
EUR
According to Wall Street analysts, the average 1-year price target for 60Q is 14.86 EUR with a low forecast of 14.72 EUR and a high forecast of 15.3 EUR.
What is the Revenue forecast for Captor Therapeutics SA?
Projected CAGR
23%
The compound annual growth rate for Revenue over the next 4 years is 23%.
What is the Gross Profit forecast for Captor Therapeutics SA?
Projected CAGR
-2%
The compound annual growth rate for Gross Profit over the next 3 years is -2%.
